The Latest in Leukemia, Myelodysplasia, Transplantation

FDA approves calaspargase pegol-mknl for ALL

December 24, 2018

CHMP backs dasatinib for kids with newly diagnosed ALL

December 19, 2018

KTE-X19 induces durable CRs, MRD negativity in ALL

December 17, 2018

Combo bests standard care in younger CLL patients

December 12, 2018

Preliminary data suggest UCART19 is safe, effective

December 12, 2018

Early switch to dasatinib offers clinical benefit to CML patients

December 10, 2018

Algorithm uncovers DS in AML patients on IDH inhibitors

December 7, 2018

Dasatinib re-challenge feasible as 2nd attempt at TKI discontinuation

December 7, 2018

ALL regimens clear disease in kids with MPAL

December 5, 2018

Serious side effect of AML treatment going unnoticed, FDA warns

November 30, 2018

FDA approves gilteritinib for relapsed/refractory AML

November 29, 2018

Pegfilgrastim biosimilar approved by EC

November 28, 2018

EC approves pegfilgrastim biosimilar

November 27, 2018

FDA grants priority review to quizartinib

November 27, 2018

CAR T-cell studies to be presented at ASH

November 24, 2018